In mouse models of cancer, Bcl-2 expression resulted in delayed tumor development in c-myc driven hepatocellular carcinoma [15], dimethylbenz(a)anthracene induced mammary tumors [16], and UV or chemical induced squamous cell carcinomas [17]. This evidence concerns the gene BCL2 and neoplasm.